Home / Letter From The Editor

Letter From The Editor

March 26, 2022

When our Publisher was doing CE programs to medical professionals, I remember he used to ask the question, “If there was a drug you could take once a day with no side effects that lowered your A1c, weight and blood pressure, how much would you be willing to pay?” Once …

Read More »

March 19, 2022

It is amazing how full drive-through windows are at coffee shops. It does not matter what time of day; there is always a line. There are people ordering plain coffee, lattes, and dozens of drinks I can’t even spell. What if in the future they could place an order for …

Read More »

March 12, 2022

Over the past few years the use of CGMs has increased significantly. More and more providers, insurers and benefit managers have seen the value of their use. Where we only had individual readings and A1c to gauge overall management success, the use of CGMs has allowed “Time in Range” to …

Read More »

March 5, 2022

Many of our patients will select a plan to manage their weight and it works, then after time it seems to reverse and all the weight your patient lost seems to magically come back. If they are using food choices the first thing we do is tell them they are …

Read More »

Feb. 26, 2022

When I looked back over the past 10 weeks of articles we have shared with you, I was amazed by the number of times we had information on the SGLT2 inhibitors in one of the editions. It is amazing how this class of drugs has gone from a third line …

Read More »

Feb. 19, 2022

We have had 56 interns help us over the past 2 years. They have researched a lot of articles for you, our readers. During this same time period, they all worked with GlucosePATH, a novel AI program to help prescribers select the best medication combinations for their patients. Recently, the …

Read More »

Feb. 12, 2022

Azeezat Rasaki, PharmD Candidate, Florida A&M University, was reviewing some older articles on the website with another intern, and they found one that talked about Alzheimer’s being caused by “type 3” diabetes. I asked them to see if there had been any updates recently, and they found some new research …

Read More »

Feb. 5, 2022

Every time there is a new consensus guide to diabetes or cardiovascular care from the experts we want to update our practices. Often we look to see who the authors are in order to validate the guidelines. This week we have the new consensus statement from the American College of …

Read More »

Jan. 29, 2022

Njideka Aginam, PharmD Candidate, South College School of Pharmacy, has been looking for solutions for weight loss for diabetes patients. He found many methods based on food choices and the times we eat. Most of these studies are done by someone trying to drive you to a program that will …

Read More »